32906785|t|Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities.
32906785|a|The interleukin 23 (IL-23) is a key pro-inflammatory cytokine in the development of chronic inflammatory diseases, such as psoriasis, inflammatory bowel diseases, multiple sclerosis, or rheumatoid arthritis. The pathological consequences of excessive IL-23 signaling have been linked to its ability to promote the production of inflammatory mediators, such as IL-17, IL-22, granulocyte-macrophage colony-stimulating (GM-CSF), or the tumor necrosis factor (TNFalpha) by target populations, mainly Th17 and IL-17-secreting TCRgammadelta cells (Tgammadelta17). Due to their pivotal role in inflammatory diseases, IL-23 and its downstream effector molecules have emerged as attractive therapeutic targets, leading to the development of neutralizing antibodies against IL-23 and IL-17 that have shown efficacy in different inflammatory diseases. Despite the success of monoclonal antibodies, there are patients that show no response or partial response to these treatments. Thus, effective therapies for inflammatory diseases may require the combination of multiple immune-modulatory drugs to prevent disease progression and to improve quality of life. Alternative strategies aimed at inhibiting intracellular signaling cascades using small molecule inhibitors or interfering peptides have not been fully exploited in the context of IL-23-mediated diseases. In this review, we discuss the current knowledge about proximal signaling events triggered by IL-23 upon binding to its membrane receptor to bring to the spotlight new opportunities for therapeutic intervention in IL-23-mediated pathologies.
32906785	9	14	IL-23	Gene	27178
32906785	72	86	interleukin 23	Gene	27178
32906785	88	93	IL-23	Gene	27178
32906785	108	120	inflammatory	Disease	MESH:D007249
32906785	152	181	chronic inflammatory diseases	Disease	MESH:D002908
32906785	191	200	psoriasis	Disease	MESH:D011565
32906785	202	229	inflammatory bowel diseases	Disease	MESH:D015212
32906785	231	249	multiple sclerosis	Disease	MESH:D009103
32906785	254	274	rheumatoid arthritis	Disease	MESH:D001172
32906785	319	324	IL-23	Gene	27178
32906785	396	408	inflammatory	Disease	MESH:D007249
32906785	428	433	IL-17	Gene	3605
32906785	435	440	IL-22	Gene	50616
32906785	485	491	GM-CSF	Gene	1437
32906785	501	522	tumor necrosis factor	Gene	7124
32906785	524	532	TNFalpha	Gene	7124
32906785	573	578	IL-17	Gene	3605
32906785	655	676	inflammatory diseases	Disease	MESH:D007249
32906785	678	683	IL-23	Gene	27178
32906785	832	837	IL-23	Gene	27178
32906785	842	847	IL-17	Gene	3605
32906785	886	907	inflammatory diseases	Disease	MESH:D007249
32906785	965	973	patients	Species	9606
32906785	1067	1088	inflammatory diseases	Disease	MESH:D007249
32906785	1396	1401	IL-23	Gene	27178
32906785	1515	1520	IL-23	Gene	27178
32906785	1635	1640	IL-23	Gene	27178
32906785	Positive_Correlation	27178	7124
32906785	Positive_Correlation	27178	50616
32906785	Association	MESH:D001172	27178
32906785	Association	MESH:D007249	1437
32906785	Association	MESH:D009103	27178
32906785	Association	MESH:D015212	27178
32906785	Association	MESH:D002908	27178
32906785	Association	MESH:D007249	27178
32906785	Association	MESH:D011565	27178
32906785	Positive_Correlation	1437	27178
32906785	Association	MESH:D007249	7124
32906785	Positive_Correlation	27178	3605
32906785	Association	MESH:D007249	3605
32906785	Association	MESH:D007249	50616

